RxDoctor Payments Data

Michael Presti, DPM

Podiatrist · Havre de Grace, MDNPI 1245344852

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 37.6% of the total. 2025 is the largest year on record at $3,446, 3.0 times the $1,140 reported in 2019.

$6,221in general payments, 2019–2025

Across 73 payments — averaging $85.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$2K
  • Convatec Inc.$2K
  • Osteomed LLC$853
  • Organogenesis Inc.$301
  • Amgen$223
  • Tactile Systems Technology Inc$145
  • plus $497 from 10 others

What the payments were for

  • Consulting fees$1002%
  • Speaking & faculty fees$120%
  • Travel & lodging$3,64359%
  • Food & beverage$2,46640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,221 in reported general payments places this provider in the 85th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$333,001
Medicare patients
1,286
Services billed
5,993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin100$2,341
Ketoconazole27$557
Methylprednisolone72$481
Meloxicam67$420
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip19$347
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$261
Cephalexin46$246
Colchicine13$171
Doxycycline Hyclate11$88
Clindamycin Hcl11$77

Paid to pharmacies, not to this prescriber.

Other podiatrist in Havre de Grace

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →